The financing will enable Monte Rosa to accelerate the growth of its pipeline, advance development candidates into the clinic and bolster its platform capabilities to rationally design and develop small molecule degraders - also known as molecular glues - that hijack the body’s innate ability to degrade proteins.

The Swisscom Startup Challenge gives start-ups and research teams access to the Swisscom 5G lab, its live network and to 5G devices during an exploration week in Switzerland. In addition, the winners will receive the support of experts and mentors from Ericsson, Qualcomm CDMA Technologies and Swisscom. The competition is open to teams from all over the world.

The Swiss startup Neo Medical and global medical devices company Orthofix Medical Inc. have announced a partnership to develop and market single-use, sterile-packaged spinal solutions. Orthofix is also investing $10 million in Neo Medical to support the ongoing partnership.

The Royal Court of Oman has selected the Swiss EdTech startup EDACY to implement a 5-week Digital Fluency online learning program developed with the EPFL. The goal was to upskill up to 10,000 of its employees.

Pureos Bioventures, a newly formed venture capital firm, will exclusively invest in innovative private drug development companies with an emphasis on novel biological drugs and emerging modalities such as nucleic acid, cell, and gene therapies. The firm is advised by Bellevue Asset Management.